Reliance Industries' shares may gain interest after Karkinos Healthcare completed HPV DNA screening for over 100,000 women in India, expanding cervical cancer care access.
Reliance Industries' shares might attract investor attention as its investee company, Karkinos Healthcare, completed HPV DNA screening for over 100,000 women across India. This significant milestone expands access to crucial cervical cancer care, potentially enhancing Karkinos'…
Market Samachar is a news aggregator. This article was originally published by mint - markets. Tap the button above to read the full story on their site.